Zamzam Al-Hashami Selected Research

Immune Checkpoint Inhibitors

10/2023	The Prevalence and Patterns of Toxicity With Immune Checkpoint Inhibitors in Solid Tumors: A Real-World Experience From a Tertiary Care Center in Oman.
1/2022	Real-world eligibility for platinum doublet plus immune checkpoint inhibitors in extensive-stage small-cell lung cancer.
1/2022	Effect of targeted therapy and immunotherapy on advanced nonsmall-cell lung cancer outcomes in the real world.
1/2022	Pulmonary toxicities of immune check point inhibitors in the management of cancer: mini review.
1/2021	Discordance in PD-L1 scores on repeat testing of non-small cell lung carcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zamzam Al-Hashami Research Topics

Disease

5	Neoplasms (Cancer) 10/2023 - 01/2022
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2023 - 01/2021
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2022 - 01/2022
1	Disease Progression 01/2023
1	Lung Neoplasms (Lung Cancer) 10/2022
1	Tuberculosis (Tuberculoses) 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Idiopathic Pulmonary Fibrosis 01/2022
1	Rheumatoid Arthritis 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Takayasu Arteritis (Arteritis, Takayasu's) 01/2022

Drug/Important Bio-Agent (IBA)

5	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2021
2	PlatinumIBA 01/2023 - 01/2022
2	pembrolizumabIBA 01/2023 - 11/2022
1	PM 01183IBA 12/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021

Therapy/Procedure

6	Therapeutics 04/2023 - 01/2022
2	Drug Therapy (Chemotherapy) 01/2023 - 01/2022
1	Duration of Therapy 01/2023
1	Immunotherapy 01/2022
1	Contraindications 01/2022